发明授权
US09403815B2 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
有权
化合物及其在调节各种淀粉样β肽异构体水平中的用途
- 专利标题: Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
- 专利标题(中): 化合物及其在调节各种淀粉样β肽异构体水平中的用途
-
申请号: US13806692申请日: 2011-06-24
-
公开(公告)号: US09403815B2公开(公告)日: 2016-08-02
- 发明人: Steven L. Wagner , Soan Cheng , William C. Mobley , Rudolph E. Tanzi
- 申请人: Steven L. Wagner , Soan Cheng , William C. Mobley , Rudolph E. Tanzi
- 申请人地址: US CA Oakland US MA Boston
- 专利权人: The Regents of the University of California,The General Hospital Corporation
- 当前专利权人: The Regents of the University of California,The General Hospital Corporation
- 当前专利权人地址: US CA Oakland US MA Boston
- 代理机构: Fish & Richardson P.C.
- 代理商 Vasily Ignatenko
- 国际申请: PCT/US2011/041905 WO 20110624
- 国际公布: WO2011/163636 WO 20111229
- 主分类号: C07D417/14
- IPC分类号: C07D417/14 ; C07F9/6558
摘要:
The invention provides a novel compound having a structure corresponding to Formula (I): (A)-(B)-(C)-(D) (I) or a pharmaceutically acceptable salt or prodrug thereof and methods for using them.